Jeffrey Sopko

Jeffrey Sopko is the President and Chief Executive Officer of Standard Molecular, a company revolutionizing oncology care through its innovative PaaS technology, ConnectOTR.

With a strong educational background in Business Administration, including a MS from The Johns Hopkins University - Carey Business School, Jeffrey Sopko has honed his skills and expertise in the healthcare industry.

Prior to his current role, Jeffrey served as the Chief Commercial Officer at Standard Molecular and held leadership positions at reputable organizations like KPMG US, Surescripts LLC, Medtronic, and Becton, Dickinson & Co.

His extensive experience includes roles such as Managing Director and Head of Industry Solutions Healthcare at KPMG Spectrum, VP/GM Diagnostics and Emerging Services at Surescripts LLC, and VP of Sales and Marketing at IvyRehab.

Jeffrey Sopko's contributions to the healthcare sector extend to companies like Medtronic, where he served as Director of Commercial Operations, and Deloitte, where he managed the National Healthcare Practice.

With a background in Executive Education from prestigious institutions like Columbia Business School and Kellogg School of Management, Jeffrey brings a wealth of knowledge to his current position at Standard Molecular, leading the way in genomic-driven patient care.

Under his leadership, Standard Molecular's ConnectOTR platform is transforming how oncologists utilize genomic data to enhance patient treatment and provide actionable insights for better outcomes.